Duloxetine significantly improved peripheral neuropathy related to oxaliplatin and was well tolerated, according to data presented at the 2021 Gastrointestinal Cancers Symposium.
“Duloxetine may be considered as an option in ameliorating peripheral neuropathy in these patients,” reported Jeffrey Chi, MD, a fellow with Northwell Health Cancer Institute in Lake Success, N.Y.
Duloxetine, a second-generation selective serotonin–norepinephrine